Literature DB >> 27530060

Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an Ethics Committee opinion.

.   

Abstract

This opinion addresses the ethics of providing fertility treatment to women at elevated risk from fertility treatment or pregnancy. Providers ethically may treat women at elevated risk provided that they are carefully assessed; that specialists in their medical condition are consulted as appropriate; and that patients are fully informed about risks, benefits, and alternatives, including oocyte and embryo donation, use of a gestational surrogate, not undergoing fertility care, and adoption. Providers also may conclude that the risks are too high for them to treat particular patients ethically; such determinations must be made in a medically objective and unbiased manner and patients must be fully informed of the decision. Counseling of women who wish to initiate fertility treatment with underlying medical conditions that confer increased risk during treatment or pregnancy should incorporate the most current knowledge available, being cognizant of the woman's personal determinants in relation to her reproductive desires. In such a way, both physician and patient will optimize decision making in an ethically sound, patient-supportive context.
Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fertility treatment; assisted reproductive technology; complications; ethics; high risk pregnancy

Mesh:

Year:  2016        PMID: 27530060     DOI: 10.1016/j.fertnstert.2016.08.015

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

1.  Acute pain crisis in a patient with sickle cell disease undergoing ovarian simulation for fertility preservation prior to curative stem cell transplantation: case report and literature review.

Authors:  Michelle Matthews; Rebecca Pollack
Journal:  J Assist Reprod Genet       Date:  2017-08-11       Impact factor: 3.412

Review 2.  Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review.

Authors:  Stefano Palomba; Roy Homburg; Susanna Santagni; Giovanni Battista La Sala; Raoul Orvieto
Journal:  Reprod Biol Endocrinol       Date:  2016-11-04       Impact factor: 5.211

3.  Provision of Fertility Services for Women at Increased Risk of Complications: Ethics Opinion.

Authors: 
Journal:  J Hum Reprod Sci       Date:  2018 Apr-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.